ACH (Accendra Health, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by ACH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Heath H Galloway | EVP,General Counsel & CorpSecy | F | — | — |
| 2026-05-19 | Edward A Pesicka | President & CEO | F | — | — |
| 2026-05-19 | Jonathan A Leon | EVP & CFO | F | — | — |
| 2026-05-19 | Perry A Bernocchi | EVP, Chief Operating Officer | F | — | — |
| 2026-05-19 | Heath H Galloway | EVP,General Counsel & CorpSecy | F | — | — |
| 2026-05-18 | Mark A Beck | Director | A | — | — |
| 2026-05-18 | Kenneth Gardner-Smith | Director | A | — | — |
| 2026-05-18 | Gwendolyn M Bingham | Director | A | — | — |
| 2026-05-18 | Teresa L. Kline | Director | A | — | — |
| 2026-05-18 | Stephen W Klemash | Director | A | — | — |
| 2026-03-24 | Jonathan A Leon | EVP & CFO | F | — | — |
| 2026-03-24 | Edward A Pesicka | President & CEO | F | — | — |
| 2026-03-24 | Perry A Bernocchi | EVP, Chief Operating Officer | F | — | — |
| 2026-03-24 | Heath H Galloway | EVP,General Counsel & CorpSecy | F | — | — |
| 2026-03-10 | Jonathan A Leon | EVP & CFO | A | — | — |
| 2026-03-10 | Perry A Bernocchi | EVP, Chief Operating Officer | A | — | — |
| 2026-03-10 | Heath H Galloway | EVP,General Counsel & CorpSecy | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President & CEO | 1,072,785 | — |
| — | EVP, Chief Operating Officer | 313,913 | — |
| — | EVP & CFO | 290,533 | — |
| — | EVP,General Counsel & CorpSecy | 166,306 | — |
| — | Director | 90,242 | — |
| — | Director | 86,113 | — |
| — | Director | 85,316 | — |
| — | Director | 71,259 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ACH quote page; the site-wide leaderboard is on the insider transactions hub.